Healthcare provider profile · identity verified

Andrew Thurman, M.D.

Family Practice · MONROE, WA · NPI 1093863219

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Oxycodone Hcl	Oxycodone Hcl	292	44
Atorvastatin Calcium	Atorvastatin Calcium	239	74
Levothyroxine Sodium	Levothyroxine Sodium	219	63
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	182	29
Gabapentin	Gabapentin	172	52
Omeprazole	Omeprazole	157	50
Losartan Potassium	Losartan Potassium	151	45
Tamsulosin Hcl	Tamsulosin Hcl	149	42
Trazodone Hcl	Trazodone Hcl	145	33
Lisinopril	Lisinopril	143	50
Metoprolol Succinate	Metoprolol Succinate	142	40
Amlodipine Besylate	Amlodipine Besylate	140	46
Alprazolam	Alprazolam	134	22
Albuterol Sulfate Hfa	Albuterol Sulfate	103	38
Jardiance	Empagliflozin	98	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	97	16
Rosuvastatin Calcium	Rosuvastatin Calcium	97	35
Tizanidine Hcl	Tizanidine Hcl	97	28
Clonazepam	Clonazepam	89	13
Bupropion Xl	Bupropion Hcl	86	20
Allopurinol	Allopurinol	85	22
Sertraline Hcl	Sertraline Hcl	85	22
Metformin Hcl	Metformin Hcl	78	23
Pantoprazole Sodium	Pantoprazole Sodium	77	22
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	73	suppressed
Atenolol	Atenolol	70	20
Furosemide	Furosemide	70	26
Hydrochlorothiazide	Hydrochlorothiazide	70	22
Ondansetron Odt	Ondansetron	65	23
Duloxetine Hcl	Duloxetine Hcl	64	19
Eliquis	Apixaban	63	15
Tramadol Hcl	Tramadol Hcl	60	15
Lorazepam	Lorazepam	57	12
Morphine Sulfate Er	Morphine Sulfate	57	suppressed
Metformin Hcl Er	Metformin Hcl	56	18
Citalopram Hbr	Citalopram Hydrobromide	54	14
Ozempic	Semaglutide	54	12
Mirtazapine	Mirtazapine	52	12
Simvastatin	Simvastatin	52	17
Trulicity	Dulaglutide	50	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	49	11
Pregabalin	Pregabalin	48	12
Escitalopram Oxalate	Escitalopram Oxalate	44	14
Telmisartan	Telmisartan	42	suppressed
Carvedilol	Carvedilol	41	12
Famotidine	Famotidine	37	suppressed
Potassium Chloride	Potassium Chloride	36	15
Diazepam	Diazepam	35	suppressed
Montelukast Sodium	Montelukast Sodium	35	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Spironolactone	Spironolactone	33	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Finasteride	Finasteride	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Promethazine Hcl	Promethazine Hcl	30	suppressed
Meloxicam	Meloxicam	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Sildenafil Citrate	Sildenafil Citrate	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	27	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Fluconazole	Fluconazole	26	11
Metoprolol Tartrate	Metoprolol Tartrate	25	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	24	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	11
Methocarbamol	Methocarbamol	23	suppressed
Mupirocin	Mupirocin	23	12
Buspirone Hcl	Buspirone Hcl	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Prednisone	Prednisone	21	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Torsemide	Torsemide	20	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	19	suppressed
Fentanyl	Fentanyl	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Doxepin Hcl	Doxepin Hcl	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Temazepam	Temazepam	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Colchicine	Colchicine	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Tramadol Hcl Er	Tramadol Hcl	15	suppressed
Baclofen	Baclofen	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Cephalexin	Cephalexin	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Estradiol	Estradiol	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error